Bengt Hoepken
- Rheumatology top 0.5%
- Immunology top 2%
- Hematology top 2%
- Ophthalmology top 5%
- Orthopedics and Sports Medicine top 10%
- Co-authors
- Désirée van der HeijdeAtul DeodharPhilip J. MeaseC. StachRobert LandewéWalter P. MaksymowychMartín RudwaleitJ. Wollenhaupt
- Topics
- Spondyloarthritis Studies and Treatments (58 papers)Psoriasis: Treatment and Pathogenesis (43 papers)Rheumatoid Arthritis Research and Therapies (41 papers)
- Cited by
- RheumatologyHematologyImmunology
- Journals
- Annals of the Rheumatic DiseasesJournal of the American Academy of DermatologyQuality of Life Research
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Bengt Hoepken
64 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 52
- Rheumatology 1.3k
- Immunology 1.0k
- Hematology 547
- Ophthalmology 97
- Orthopedics and Sports Medicine 81
Countries citing papers authored by Bengt Hoepken
This map shows the geographic impact of Bengt Hoepken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Hoepken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Hoepken more than expected).
Fields of papers citing papers by Bengt Hoepken
This network shows the impact of papers produced by Bengt Hoepken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Hoepken. The network helps show where Bengt Hoepken may publish in the future.
Co-authorship network of co-authors of Bengt Hoepken
This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Hoepken. A scholar is included among the top collaborators of Bengt Hoepken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Hoepken. Bengt Hoepken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 47 | |
| 11 | 22 | |
| 12 | 4 | |
| 13 | 30 | |
| 14 | 90 | |
| 15 | CERTOLIZUMAB PEGOL FOR THE TREATMENT OF PSORIATIC ARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-PSA TRIAL | 2 |
| 16 | Long-Term Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis with and without Prior Tumor Necrosis Factor Inhibitor Exposure | 1 |
| 17 | Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis | 3 |
| 18 | EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE : 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY | 4 |
| 19 | Effect Of Certolizumab Pegol Over 48 Weeks On Signs and Symptoms In Patients With Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Exposure | 3 |
| 20 | Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis : 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study | 10 |
About Bengt Hoepken
Bengt Hoepken is a scholar working on Rheumatology, Immunology and Hematology, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (58 papers), Psoriasis: Treatment and Pathogenesis (43 papers) and Rheumatoid Arthritis Research and Therapies (41 papers). The work is most often cited by research in Rheumatology (1.3k citations), Hematology (547 citations) and Immunology (1.0k citations). Bengt Hoepken has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Désirée van der Heijde, Atul Deodhar, Philip J. Mease, C. Stach, Robert Landewé, Walter P. Maksymowych, Martín Rudwaleit, J. Wollenhaupt, Roy Fleischmann and Danuta Kielar. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and Quality of Life Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.